Outcome of High-Dose Therapy and Autologous Transplantation in Non-Hodgkin's Lymphoma Based on the Presence of Tumor in the Marrow or Infused Hematopoietic Harvest

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 214-219

  Sharp, J G ^a   Kessinger, A ^a   Mann, S ^a   Crouse, D A ^a   Armitage, J O ^a   Bierman, P ^a   Weisenburger, D D ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CONTAMINATION; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; BONE MARROW; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0030030050     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.214     Document Type: Article

References (20)

1. Armitage JO: Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma. Bone Marrow Transplant 10:62-63, 1992
2. Kessinger A: Re-establishing hematopoiesis after dose-intensive therapy with peripheral stem cells, in Armitage JO, Antman K (eds): High-Dose Cancer Therapy (ed 2). Baltimore, MD, Williams & Wilkins, 1995, pp 196-210
3. Goldstone AH, McMillian AK, Chopra R. High-dose therapy for the treatment of non-Hodgkin's lymphoma, in Armitage JO, Antman K (eds): High-Dose Cancer Therapy (ed 2). Baltimore, MD, Williams & Wilkins, 1995, pp 757-779
4. Ratanatharathorn V, Uberti J, Karanes C, et al: Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 84:1050-1055, 1994
5. Joshi SS, Kessinger A, Mann SL, et al: Detection of tumor cells in histologically normal bone marrow using culture techniques. Bone Marrow Transplant 1:303-310, 1987
6. Sharp JG, Kessinger MA, Pirrucello SJ, et al: Frequency of detection of suspected lymphoma cells in peripheral blood stem cell collections, in Dicke KA, Armitage JO, Evinger-Dicke MJ (eds): Autologous Bone Marrow Transplantation V. Omaha, NE, University of Nebraska Medical Center, 1994, pp 801-810
7. Sharp JG, Joshi SS, Armitage JO, et al: Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved hone marrow by a culture technique. Blood 79:1074-1080, 1992
8. Sharp JG, Kessinger A, Armitage JO, et al: Clinical significance of occult tumor cell contamination of hematopoietic harvests in non-Hodgkin's lymphoma and Hodgkin's disease, in Zander A, Barlogie B (eds): Proceedings of an International Symposium on ABMT for Lymphomas, Hodgkin's Disease and Myeloma. New York, NY, Springer-Verlag, 1992, pp 123-132
9. Langlands K, Craig J, Parker AC: Molecular determination of minimal residual disease in peripheral blood stem cell harvests. Bone Marrow Transplant 5:64-65, 1990
10. Langlands K, Anderson JS, Parker AC, et al: Polymerase chain reaction analysis of tumour contamination in peripheral blood stem cell harvests. Int J Cell Cloning 10:95-97, 1992
11. Weisenburger DD, Daley DT, Armitage JO, et al: Intermediate lymphocytic lymphoma: An immunohistologic study with comparison to other lymphocytic lymphomas. Hum Pathol 18:781-790, 1987
12. Linder J, Ye YL, Armitage JO, et al: Monoclonal antibodies marking T-lymphocytes in paraffin-embedded tissue. Am J Pathol 127:1-8, 1987
13. Linder J, Ye YL, Armitage JO, et al: Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin embedded tissue. Mod Pathol 1:29-34, 1988
14. Philip I, Philip T, Favrot MC: Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt's lymphoma. J Natl Cancer Inst 73:835-840, 1984
15. Douay L, Lefrancois G, Castaign S, et al: Long-term human blood cultures: application to circulating progenitor cell autographing. Bone Marrow Transplant 2:67-72, 1987
16. Joshi SS, Novak DJ, Messbarger L, et al: Levels of detection of tumor cells in human bone marrow with or without prior culture. Bone Marrow Transplant 6:179-183, 1990
17. Shipp MA: Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has "high-risk" disease? Blood 83:1165-1173, 1994
18. Brenner MK, Rill DR, Moen RC, et al: Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85-86, 1993
19. Rill DR, Santana VM, Roberts WM, et al: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383, 1994
20. Gribben JG, Freedmon AS, Neuberg D, et al: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525-1533, 1991